Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin receptor type 3 (5-HT₃ receptor) is a member of the Cys-loop superfamily of ligand-gated ion channels and is structurally and functionally distinct from other serotonin (5-HT) receptors, which are G protein-coupled receptors[1][5][6][3]. The 5-HT₃ receptor forms a pentameric structure that acts as a cation-selective channel permeable to sodium, potassium, and calcium. It plays a pivotal role in fast excitatory neurotransmission in both the central and peripheral nervous systems and is highly expressed in areas related to emesis, including the brainstem and gastrointestinal tract[1][3][6][9]. Activation of the 5-HT₃ receptor by serotonin results in rapid neuronal depolarization, leading to effects such as vomiting, nausea, and modulation of gut motility. Clinically, pharmacological antagonists of the 5-HT₃ receptor are widely used to treat and prevent nausea and vomiting, particularly in the context of chemotherapy, radiotherapy, and postoperative recovery[7][9]. The receptor is also being studied in relation to additional CNS and gastrointestinal disorders.
Antagonism (blockade) of serotonin binding at the 5-HT₃ receptor; Inhibition of ligand-gated cation channel opening
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin receptor type 3 (5-HT₃ receptor).